# Calcium Channel Blocker Toxicity

Manage suspected calcium channel blocker toxicity as a time-critical cardiovascular poisoning: establish invasive-ready monitoring, treat bradycardia and shock in parallel, begin vasopressors and high-dose insulin early for significant hypotension, and escalate refractory cardiogenic shock to mechanical circulatory support.

**Clinical question:** How should physicians stabilize and escalate treatment for adult calcium channel blocker poisoning with bradycardia, hypotension, or cardiogenic shock?

Updated: 2026-09-15T23:59:59.690652+00:00

## What matters in practice
- Clinically significant calcium channel blocker poisoning requires immediate cardiovascular monitoring, vascular access, and parallel treatment of bradycardia and hypotension rather than sequential trials of low-yield interventions. [7][23]
- Atropine is a standard first-line treatment for bradycardia but is rarely effective in serious poisoning; do not delay calcium, vasopressors, or high-dose insulin for an atropine response. [7]
- For significant hypotension, initiate vasopressors and consider high-dose insulin with dextrose early; high-dose insulin is used to support myocardial contractility in severe calcium channel blocker poisoning. [7][20]
- IV calcium chloride may have only minimal or short-lived benefit in severe poisoning; repeat boluses or continuous infusion may be required while definitive hemodynamic support is established. [7]
- Persistent shock despite calcium, vasopressors, and high-dose insulin warrants urgent consideration of extracorporeal membrane oxygenation or cardiopulmonary bypass. [7]

## Identify patients who need resuscitation-level treatment

Treat hemodynamic instability as severe poisoning until proven otherwise.

Place patients with bradycardia, hypotension, conduction disturbance, altered perfusion, or evolving shock on continuous cardiac monitoring. Obtain immediate IV access; in significant hypotension, place a central venous line and consider an arterial line to support vasoactive infusions and continuous blood-pressure assessment. [7]

Use the initial ECG and serial bedside hemodynamics to guide resuscitation. Nondihydropyridine agents, including diltiazem and verapamil, have direct AV-nodal effects through L-type calcium-channel blockade and are therefore particularly relevant when bradycardia or AV conduction delay accompanies hypotension. [8]

Start IV crystalloids as an initial measure, but do not allow fluid administration to defer pharmacologic support when hypotension persists. Initial management of calcium channel blocker overdose typically includes IV crystalloids and gastrointestinal decontamination; subsequent treatment should be driven by the presence and severity of bradycardia, hypotension, and shock. [23]
- Activate poison center or bedside medical toxicology support early when there is cardiovascular instability, because treatment commonly requires simultaneous antidotal and vasoactive therapies. [7][20]
- Secure airway and ventilation when mental status, respiratory failure, seizures, or shock prevents safe airway protection; seizures should be treated with IV benzodiazepines, with barbiturates or propofol for persistent or recurrent seizures. [7]
- Use an arterial line when shock is clinically significant or escalating, particularly when titrating vasopressors and high-dose insulin. [7]

*Immediate treatment priorities are determined by the dominant cardiovascular phenotype. [7][23]*

| Presentation | Immediate action | What changes next |
| --- | --- | --- |
| Bradycardia with preserved or mildly reduced blood pressure | Give atropine as first-line bradycardia therapy while preparing escalation. [7] | Failure to respond is common in serious poisoning; add hemodynamic therapies rather than repeating ineffective atropine. [7] |
| Significant hypotension or shock | Give IV crystalloids, begin vasopressors, administer IV calcium, and consider early high-dose insulin with dextrose. [7][23] | Persistent instability indicates severe poisoning and should prompt invasive monitoring and extracorporeal-support planning. [7] |
| Seizure or recurrent seizure | Treat with IV benzodiazepines; use barbiturates or propofol if seizures persist or recur. [7] | Continue concurrent cardiovascular resuscitation because seizure control does not correct toxic myocardial dysfunction. [7] |

## Use calcium, vasopressors, and high-dose insulin in parallel for severe toxicity

Choose therapy according to the urgency of circulatory failure, not a rigid antidote sequence.

Administer IV calcium in severe poisoning; calcium chloride is preferred in the cited management approach. Expect that benefit may be minimal or transient in advanced toxicity, and use repeat boluses or a continuous IV infusion when a response is observed but not sustained. [7]

Start standard vasopressors to maintain blood pressure in clinically significant hypotension. A published clinical discussion emphasizes that severe calcium channel blocker poisoning often requires a tailored combination of calcium, high-dose insulin, and vasoactive support rather than reliance on a single therapy. [7][18]

Consider high-dose insulin euglycemic therapy early for substantial hypotension refractory to initial measures or when severe poisoning is apparent. High-dose insulin with glucose supplementation is used to support myocardial contractility; the commonly reported bolus dose in successful cases and current guideline-based practice is 1 unit/kg. [7][15][20]

Administer dextrose with high-dose insulin to maintain euglycemia and monitor glucose closely throughout therapy. The operational requirement is adapted glucose supplementation, because high-dose insulin therapy is specifically intended to be euglycemic rather than to induce hypoglycemia. [20][21]
- Do not interpret a poor atropine response as treatment failure; it is expected in serious calcium channel blocker poisoning. [7]
- Do not rely on calcium alone when shock is progressive; its hemodynamic effect can be brief, requiring concurrent vasopressors and high-dose insulin. [7][18]
- When using high-dose insulin, ensure capacity for frequent glucose surveillance and continuous dextrose adjustment before and during infusion. [20][21]

### Adjuncts for refractory instability

IV glucagon has been used with variable success and should not displace therapies with more established roles in severe hypotension, including vasopressors, IV calcium, and high-dose insulin. [7]

Consider IV lipid emulsion only for hypotension refractory to other therapies; reported experience is largely animal data and case reports, and lipid emulsion has been associated with adverse effects including acute respiratory distress syndrome. [7][17]
- Treat first-degree AV block according to the relevant bradycardia/conduction-management pathway while addressing the toxicologic cause and circulatory state. [7]
- Escalate early if vasoactive requirements rise or end-organ perfusion remains inadequate despite combined therapy. [7]

*Hemodynamic therapies and escalation decisions in severe calcium channel blocker poisoning. [7][15][17][20]*

| Therapy | When to use | Key limitation or monitoring need |
| --- | --- | --- |
| Atropine | Initial bradycardia treatment. [7] | Rarely effective in serious poisoning; do not delay escalation. [7] |
| IV calcium chloride | Severe poisoning, especially with hypotension or conduction effects. [7] | Effect may be minimal or short lived; repeat bolus dosing or infusion may be needed. [7] |
| Vasopressors | Hypotension requiring pharmacologic blood-pressure support. [7] | Titrate to hemodynamic response with invasive monitoring when feasible. [7] |
| High-dose insulin with dextrose | Significant hypotension or shock, particularly when refractory to initial modalities. [7][20] | A 1-unit/kg bolus is commonly reported; use glucose supplementation and euglycemia monitoring. [15][20] |
| IV lipid emulsion | Hypotension refractory to other therapies. [7] | Evidence cited includes animal studies and case reports; ARDS has been reported. [7][17] |

## Pair gastrointestinal decontamination with continuous reassessment

Decontamination complements, but never substitutes for, cardiovascular resuscitation.

Include gastrointestinal decontamination in the initial strategy when clinically appropriate, alongside IV crystalloids and cardiac monitoring. Do not delay treatment of bradycardia, hypotension, or shock while pursuing decontamination. [23]

Reassess blood pressure, heart rate, rhythm, perfusion, neurologic status, and glucose repeatedly after each escalation. High-dose insulin requires ongoing dextrose supplementation to maintain euglycemia, while calcium therapy may require repeated dosing or infusion because benefit can be transient. [7][20]

Avoid assuming clinical stability from a single favorable response to calcium or fluids. Escalating vasopressor needs, recurrent hypotension, or persistent evidence of cardiogenic shock should trigger early consultation for extracorporeal support rather than prolonged cycling among temporizing therapies. [7]
- Use continuous ECG monitoring for bradyarrhythmia and AV conduction effects, particularly after diltiazem or verapamil exposure. [8]
- Monitor glucose closely during high-dose insulin with dextrose supplementation. [20][21]
- Use serial arterial pressure measurements when shock or vasoactive infusions require precise titration. [7]

*Monitoring findings that should alter management in severe poisoning. [7][20][21]*

| Finding | Interpretation | Next action |
| --- | --- | --- |
| Persistent hypotension after crystalloids | Fluid-only treatment is inadequate. [7][23] | Start or increase vasopressors; give IV calcium and consider early high-dose insulin with dextrose. [7] |
| Bradycardia unresponsive to atropine | Serious toxic bradycardia may not respond to atropine. [7] | Escalate circulatory support rather than relying on repeated atropine. [7] |
| Need for ongoing glucose supplementation during high-dose insulin | Expected consequence of euglycemic high-dose insulin therapy. [20][21] | Continue frequent glucose monitoring and adjust dextrose to maintain euglycemia. [20] |
| Shock refractory to combined calcium, vasopressor, and high-dose insulin therapy | Refractory cardiovascular toxicity. [7] | Urgently evaluate for ECMO or cardiopulmonary bypass. [7] |

## Escalate refractory cardiogenic shock to extracorporeal support

Mechanical circulatory support is a rescue strategy for persistent hemodynamic collapse.

Consider extracorporeal membrane oxygenation or cardiopulmonary bypass when hemodynamic status remains refractory despite IV calcium, vasopressors, high-dose insulin with dextrose, and other indicated rescue measures. [7]

Begin transfer and perfusion-capable-center discussions before cardiovascular collapse becomes irreversible. The escalation threshold is not a fixed dose or laboratory value; it is persistent shock despite appropriately deployed combined pharmacologic therapy. [7][18]

Continue vasopressors, high-dose insulin with glucose supplementation, calcium as indicated, seizure control, and invasive monitoring while extracorporeal support is being arranged. [7][20]
- Do not postpone extracorporeal-support consultation until every adjunct has been exhausted if shock remains refractory to the core combination of calcium, vasopressors, and high-dose insulin. [7][18]
- Use IV lipid emulsion as a possible refractory adjunct, recognizing the limited nature of the cited efficacy data and reported respiratory risk. [7][17]

*Refractory-shock pathway in calcium channel blocker toxicity. [7][17][18]*

| Status | Required treatment posture | Escalation |
| --- | --- | --- |
| Hypotension responsive to initial therapy | Continue monitored calcium, vasopressor, and glucose-supported insulin strategy as clinically indicated. [7][20] | Maintain continuous reassessment for recurrent instability. [7] |
| Hypotension requiring multiple concurrent therapies | Use invasive monitoring and coordinated critical-care/toxicology management. [7][18] | Initiate early discussion with an ECMO-capable center. [7] |
| Persistent shock despite combined therapy | Continue active resuscitation during mobilization of definitive support. [7] | Consider ECMO or cardiopulmonary bypass. [7] |

## References
1. [PDF] DIGOXIN - DailyMed — dailymed.nlm.nih.gov — https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0a88434e-4a1b-4ade-a51e-38145e22a232
2. The management of adult patients with severe chronic small ... - Gut — gut.bmj.com — https://gut.bmj.com/content/gutjnl/early/2020/08/21/gutjnl-2020-321631.full.pdf
3. Heatstroke | New England Journal of Medicine — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMra1810762
4. The management of adult patients with severe chronic small intestinal dysmotility | Gut — gut.bmj.com — https://gut.bmj.com/content/69/12/2074
5. High-dose insulin euglycaemic therapy for a severe calcium channel ... — casereports.bmj.com — https://casereports.bmj.com/content/19/3/e268547
6. Multi-organ dysfunction as a presentation of calcium channel ... — casereports.bmj.com — https://casereports.bmj.com/content/15/1/e245711
7. Investigating the effect of verapamil on preservation of beta-cell function in adults with newly diagnosed type 1 diabetes mellitus (Ver-A-T1D): protocol for a randomised, double-blind, placebo-controlled, parallel-group, multicentre trial | BMJ Open — bmjopen.bmj.com — https://bmjopen.bmj.com/content/14/11/e091597
8. AHA/ACC/HRS Practice Guideline — www.ahajournals.org — https://www.ahajournals.org/doi/pdf/10.1161/cir.0000000000000041
9. 2018 ACC/AHA/HRS Guideline on the Evaluation and ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000000628
10. 2018 ACC/AHA/HRS Guideline on the Evaluation and ... - JACC — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2018.10.043
11. Part 9: Adult Advanced Life Support: 2025 ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000001376
12. Part 3: Adult Basic and Advanced Life Support: 2020 ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000000916
13. Heat-Related Illnesses - ACP Journals — www.acpjournals.org — https://www.acpjournals.org/doi/pdf/10.7326/ANNALS-25-01958
14. Abstracts - 2018 - Anaesthesia - Wiley Online Library — associationofanaesthetists-publications.onlinelibrary.wiley.com — https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.14377
15. An Overview of Hyperinsulinemic‐Euglycemic Therapy in Calcium ... — accpjournals.onlinelibrary.wiley.com — https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2177
16. Insulin improves heart function and metabolism during non ... — academic.oup.com — https://academic.oup.com/cardiovascres/article/34/2/289/331661
17. Case series: Acute management of prescription and nonprescription ... — accpjournals.onlinelibrary.wiley.com — https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1931
18. High‐dose insulin should NOT be used without vasopressors in ... — bpspubs.onlinelibrary.wiley.com — https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.15642
19. Pediatric antiarrhythmics and toxicity: A clinical review — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1002/emp2.13090
20. Calcium channel antagonist and beta‐blocker overdose: antidotes ... — bpspubs.onlinelibrary.wiley.com — https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.12763
21. High‐dose insulin should be used before vasopressors/inotropes in ... — bpspubs.onlinelibrary.wiley.com — https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bcp.15641
22. Surgical Critical Care and Emergency Surgery: Clinical Questions ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/chapter-epub/10.1002/9781119756781.index
23. Management of calcium channel blocker overdoses - Shenoy - 2014 — shmpublications.onlinelibrary.wiley.com — https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.2241
24. release - Association of Anaesthetists — associationofanaesthetists-publications.onlinelibrary.wiley.com — https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2044.2008.05477.x

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.